2576 — Zhejiang Taimei Medical Technology Co Income Statement
0.000.00%
Last trade - 00:00- HK$2.37bn
- HK$1.21bn
- CNY551.16m
- 36
- 13
- 24
- 10
Annual income statement for Zhejiang Taimei Medical Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 466 | 549 | 573 | 551 |
| Cost of Revenue | ||||
| Gross Profit | 164 | 185 | 179 | 225 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 972 | 992 | 970 | 804 |
| Operating Profit | -506 | -443 | -397 | -252 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | -480 | -423 | -356 | -217 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -480 | -423 | -356 | -217 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -480 | -413 | -347 | -215 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -480 | -413 | -347 | -215 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.793 | -0.697 | -0.577 | -0.308 |